Hikal scores in CRAMS

Hikal is busy consolidating its position in the Indian CRAMs (contract research and manufacturing services) space.

It recently secured a long-term contract with Bayer CropScience for supply of active ingredients for crop protection chemicals. And now Hikal plans to invest Rs 2bn (US$50m) in setting up four new manufacturing facilities in Bangalore and Mumbai and an R&D centre in Pune.

The facility at Mumbai will be a multipurpose one to meet Bayer’s requirement while the one in Bangalore will supply APIs (active pharmaceutical ingredients) to Pfizer and Alpharma.

Subscribe

Subscribe to our e-mail newsletter to receive updates.

, , , , , , , ,

Leave a Reply